Handel Achieve Life Sciences, Inc. - ACHV CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.27 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | 4.87 |
| Åben* | 4.88 |
| 1-Års Ændring* | -1.21% |
| Dagens Spænd* | 4.79 - 4.95 |
| 52-Ugers Spænd | 2.00-8.13 |
| Gennemsnitlig Volumen (10 dage) | 110.83K |
| Gennemsnitlig Volumen (3 måneder) | 2.13M |
| Market Cap | 78.54M |
| P/E-forhold | -100.00K |
| Udestående aktier | 17.93M |
| Omsætning | N/A |
| EPS | -4.06 |
| Dividend (Udbytte %) | N/A |
| Beta | 1.46 |
| Næste indtjeningsopgørelse | May 10, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 4.91 | 0.03 | 0.61% | 4.88 | 4.95 | 4.79 |
| Jun 28, 2022 | 4.87 | -0.23 | -4.51% | 5.10 | 5.20 | 4.85 |
| Jun 27, 2022 | 5.10 | 0.02 | 0.39% | 5.08 | 5.14 | 4.91 |
| Jun 24, 2022 | 5.15 | 0.05 | 0.98% | 5.10 | 5.24 | 5.00 |
| Jun 23, 2022 | 5.06 | -0.08 | -1.56% | 5.14 | 5.32 | 5.06 |
| Jun 22, 2022 | 5.12 | 0.03 | 0.59% | 5.09 | 5.37 | 5.09 |
| Jun 21, 2022 | 5.29 | -0.24 | -4.34% | 5.53 | 5.63 | 5.28 |
| Jun 17, 2022 | 5.49 | 0.01 | 0.18% | 5.48 | 5.69 | 5.34 |
| Jun 16, 2022 | 5.48 | -0.35 | -6.00% | 5.83 | 5.83 | 5.45 |
| Jun 15, 2022 | 5.90 | -0.05 | -0.84% | 5.95 | 6.07 | 5.82 |
| Jun 14, 2022 | 5.94 | -0.13 | -2.14% | 6.07 | 6.12 | 5.87 |
| Jun 13, 2022 | 5.99 | -0.22 | -3.54% | 6.21 | 6.25 | 5.92 |
| Jun 10, 2022 | 6.39 | -0.16 | -2.44% | 6.55 | 6.55 | 6.39 |
| Jun 9, 2022 | 6.57 | 0.06 | 0.92% | 6.51 | 6.63 | 6.51 |
| Jun 8, 2022 | 6.58 | 0.19 | 2.97% | 6.39 | 6.60 | 6.39 |
| Jun 7, 2022 | 6.55 | 0.09 | 1.39% | 6.46 | 6.62 | 6.39 |
| Jun 6, 2022 | 6.47 | -0.14 | -2.12% | 6.61 | 6.71 | 6.46 |
| Jun 3, 2022 | 6.63 | -0.03 | -0.45% | 6.66 | 6.74 | 6.56 |
| Jun 2, 2022 | 6.60 | 0.04 | 0.61% | 6.56 | 6.63 | 6.56 |
| Jun 1, 2022 | 6.54 | -0.23 | -3.40% | 6.77 | 6.80 | 6.42 |
Achieve Life Sciences, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| No events scheduled | ||
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Omsætning | |||||
| Totale Driftsudgifter | 33.094 | 14.75 | 16.528 | 12.813 | 5.16 |
| Salgs/Generelle/Admin. Udgifter, Total | 9.128 | 7.868 | 6.854 | 6.945 | 3.531 |
| Forskning & Udvikling | 23.966 | 6.882 | 9.674 | 5.868 | 3.101 |
| Usædvanlig Udgift (Indkomst) | 0 | 0 | -1.472 | ||
| Driftsindtægter | -33.094 | -14.75 | -16.528 | -12.813 | -5.16 |
| Renteindkomst (Udgift), Netto Ikke-Drift | 0.017 | 0.069 | 0.17 | 0.171 | 0.021 |
| Andre, Netto | -0.075 | -0.049 | -0.037 | -0.045 | 0.115 |
| Netto Indkomst Før Skat | -33.152 | -14.73 | -16.395 | -12.687 | -13.634 |
| Netto Indkomst Efter Skat | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Netto Indkomst Før Ekstra Ting | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Netto Indkomst | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Fortyndet Netto Indkomst | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Fortyndet Vægtet Gennemsnit Aktier | 8.11984 | 2.71891 | 0.41232 | 0.17551 | 0.02397 |
| Fortyndet EPS Uden Ekstraordinære Ting | -4.08284 | -5.41761 | -39.7628 | -72.2861 | -441.473 |
| Fortyndet Normaliseret EPS | -4.08284 | -5.41761 | -39.7628 | -72.2861 | -247.927 |
| Gain (Loss) on Sale of Assets | 0 | 0 | -8.61 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Totale Driftsudgifter | 7.226 | 7.115 | 6.693 | 11.302 | 7.984 |
| Salgs/Generelle/Admin. Udgifter, Total | 2.838 | 2.609 | 2.102 | 2.075 | 2.342 |
| Forskning & Udvikling | 4.388 | 4.506 | 4.591 | 9.227 | 5.642 |
| Driftsindtægter | -7.226 | -7.115 | -6.693 | -11.302 | -7.984 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -0.353 | 0.003 | 0.003 | 0.003 | 0.008 |
| Andre, Netto | 0.006 | -0.039 | -0.001 | -0.012 | -0.023 |
| Netto Indkomst Før Skat | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Netto Indkomst Efter Skat | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Netto Indkomst Før Ekstra Ting | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Netto Indkomst | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Fortyndet Netto Indkomst | -7.573 | -7.151 | -6.691 | -11.311 | -7.999 |
| Fortyndet Vægtet Gennemsnit Aktier | 9.45875 | 9.4682 | 9.45224 | 7.3906 | 6.13182 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.80063 | -0.75527 | -0.70787 | -1.53046 | -1.30451 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -0.80063 | -0.75527 | -0.70787 | -1.53046 | -1.30451 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 44.594 | 36.975 | 17.334 | 15.537 | 5.908 |
| Likvider og Kortsigtede Investeringer | 43.022 | 35.853 | 16.664 | 14.604 | 5.284 |
| Cash | |||||
| Likvider & Lignende | 43.022 | 35.853 | 16.664 | 9.515 | 5.284 |
| Kortsigtede Investeringer | 5.089 | ||||
| Totale Tilgodehavender, Netto | 0.153 | 0.008 | 0.007 | 0.009 | |
| Accounts Receivable - Trade, Net | 0.008 | 0.007 | 0.009 | ||
| Prepaid Expenses | 1.419 | 1.122 | 0.662 | 0.926 | 0.393 |
| Total Assets | 47.516 | 40.298 | 21.078 | 19.084 | 9.892 |
| Property/Plant/Equipment, Total - Net | 0.079 | 0.188 | 0.386 | 0.035 | 0.059 |
| Property/Plant/Equipment, Total - Gross | 0.366 | 0.82 | 0.986 | 0.755 | 1.144 |
| Accumulated Depreciation, Total | -0.287 | -0.632 | -0.6 | -0.72 | -1.085 |
| Other Long Term Assets, Total | 0.168 | 0.237 | 0.237 | 0.168 | 0.359 |
| Total Current Liabilities | 4.55 | 2.935 | 2.869 | 3.27 | 2.013 |
| Accounts Payable | 0.841 | 0.332 | 0.859 | 0.144 | 0.213 |
| Accrued Expenses | 3.709 | 2.603 | 2.01 | 3.126 | 1.773 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.027 | ||||
| Other Current Liabilities, Total | 0 | ||||
| Total Liabilities | 19.474 | 3.012 | 3.028 | 3.282 | 2.013 |
| Total Long Term Debt | 14.92 | 0 | 0 | 0 | 0 |
| Long Term Debt | 14.92 | ||||
| Total Equity | 28.042 | 37.286 | 18.05 | 15.802 | 7.879 |
| Common Stock | 0.079 | 0.076 | 0.041 | 0.018 | 0.012 |
| Additional Paid-In Capital | 121.545 | 97.64 | 63.709 | 41.161 | 20.556 |
| Retained Earnings (Accumulated Deficit) | -93.586 | -60.434 | -45.704 | -25.381 | -12.694 |
| Other Equity, Total | 0.004 | 0.004 | 0.004 | 0.004 | 0.005 |
| Total Liabilities & Shareholders’ Equity | 47.516 | 40.298 | 21.078 | 19.084 | 9.892 |
| Total Common Shares Outstanding | 9.45354 | 6.11174 | 1.47426 | 0.33606 | 0.05978 |
| Other Current Assets, Total | 0 | 0.222 | |||
| Goodwill, Net | 1.034 | 1.034 | 1.034 | 1.034 | 1.034 |
| Intangibles, Net | 1.641 | 1.864 | 2.087 | 2.31 | 2.532 |
| Deferred Income Tax | 0 | ||||
| Other Liabilities, Total | 0.004 | 0.077 | 0.159 | 0.012 | |
| Total Preferred Shares Outstanding | 0 | 0.00112 | 0.00058 | ||
| Redeemable Preferred Stock | 0 | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 37.692 | 44.594 | 34.733 | 42.431 | 30.439 |
| Likvider og Kortsigtede Investeringer | 36.337 | 43.022 | 33.312 | 42.001 | 29.637 |
| Likvider & Lignende | 36.337 | 43.022 | 33.312 | 42.001 | 29.637 |
| Prepaid Expenses | 1.355 | 1.419 | 1.27 | 0.43 | 0.802 |
| Total Assets | 40.614 | 47.516 | 37.799 | 45.565 | 33.662 |
| Property/Plant/Equipment, Total - Net | 0.049 | 0.079 | 0.1 | 0.121 | 0.141 |
| Goodwill, Net | 1.034 | 1.034 | 1.034 | 1.034 | 1.034 |
| Intangibles, Net | 1.586 | 1.641 | 1.697 | 1.752 | 1.809 |
| Other Long Term Assets, Total | 0.253 | 0.168 | 0.235 | 0.227 | 0.239 |
| Total Current Liabilities | 4.01 | 4.55 | 3.076 | 4.67 | 3.515 |
| Accounts Payable | 0.418 | 0.841 | 0.815 | 0.575 | 0.585 |
| Accrued Expenses | 3.592 | 3.709 | 2.261 | 4.095 | 2.93 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 19.181 | 19.474 | 3.099 | 4.711 | 3.574 |
| Total Long Term Debt | 15.171 | 14.92 | 0 | 0 | 0 |
| Other Liabilities, Total | 0 | 0.004 | 0.023 | 0.041 | 0.059 |
| Total Equity | 21.433 | 28.042 | 34.7 | 40.854 | 30.088 |
| Redeemable Preferred Stock | 0 | ||||
| Common Stock | 0.079 | 0.079 | 0.079 | 0.079 | 0.076 |
| Additional Paid-In Capital | 122.509 | 121.545 | 121.052 | 120.515 | 98.441 |
| Retained Earnings (Accumulated Deficit) | -101.159 | -93.586 | -86.435 | -79.744 | -68.433 |
| Other Equity, Total | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
| Total Liabilities & Shareholders’ Equity | 40.614 | 47.516 | 37.799 | 45.565 | 33.662 |
| Total Common Shares Outstanding | 9.47358 | 9.45354 | 9.45354 | 9.45222 | 6.14992 |
| Total Preferred Shares Outstanding | 0 | 0 | |||
| Totale Tilgodehavender, Netto | 0 | 0.153 | 0.151 | ||
| Long Term Debt | 15.171 | 14.92 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netto indkomst/Startlinje | -33.152 | -14.73 | -16.395 | -12.687 | -10.583 |
| Likvider Fra Driftsaktiviteter | -29.44 | -13.474 | -15.216 | -10.623 | -9.107 |
| Likvider Fra Driftsaktiviteter | 0.027 | 0.032 | 0.031 | 0.06 | 0.059 |
| Ikke-Likvide Ting | 2.228 | 1.286 | 1.198 | 0.854 | 7.336 |
| Ændringer i Driftskapital | 1.234 | -0.285 | -0.273 | 0.928 | -3.091 |
| Likvider fra Investeringsaktiviteter | -0.017 | 5.036 | -5.125 | 12.648 | |
| Kapitaludgifter | -0.017 | -0.053 | -0.046 | ||
| Andre Investerings-Cash-Flow-Ting, Total | 5.089 | -5.079 | 12.648 | ||
| Likvider fra Financieringsaktiviteter | 36.61 | 32.68 | 17.325 | 19.757 | 2.001 |
| Financiering af Cash-Flow-Ting | 27.87 | 12.334 | 4.96 | 1.937 | |
| Udstedelse (Pensionering) af Aktier, Netto | 21.681 | 4.81 | 4.991 | 14.797 | 0.064 |
| Udenlandsk Børs Effekter | -0.001 | 0.004 | 0 | -0.001 | |
| Netto Ændring i Likviditet | 7.169 | 19.189 | 7.149 | 4.009 | 5.541 |
| Amortization | 0.223 | 0.223 | 0.223 | 0.222 | 0.223 |
| Deferred Taxes | -3.051 | ||||
| Udstedelse (Pensionering) af Gæld, Netto | 14.929 | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.573 | -33.152 | -26.001 | -19.31 | -7.999 |
| Cash From Operating Activities | -6.779 | -29.44 | -24.222 | -15.528 | -6.452 |
| Cash From Operating Activities | 0.25 | 0.188 | 0.127 | 0.064 | |
| Non-Cash Items | 1.12 | 2.228 | 1.734 | 1.204 | 0.565 |
| Changes in Working Capital | -0.386 | 1.234 | -0.143 | 2.451 | 0.918 |
| Cash From Investing Activities | 0 | 0 | 0 | ||
| Capital Expenditures | 0 | 0 | 0 | ||
| Cash From Financing Activities | 0.095 | 36.61 | 21.682 | 21.674 | 0.236 |
| Issuance (Retirement) of Stock, Net | 0.024 | 21.681 | 21.682 | 21.674 | 0.236 |
| Net Change in Cash | -6.685 | 7.169 | -2.541 | 6.148 | -6.216 |
| Financing Cash Flow Items | 0.071 | 0 | 0 | ||
| Foreign Exchange Effects | -0.001 | -0.001 | -0.001 | 0.002 | |
| Issuance (Retirement) of Debt, Net | 14.929 | ||||
| Amortization | 0.06 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| B. Riley Asset Management, LLC | Investment Advisor/Hedge Fund | 19.4865 | 3494000 | 0 | 2023-03-01 | MED |
| Contrarian Alpha Management, L.L.C. | Corporation | 7.6288 | 1367873 | 1367873 | 2022-11-18 | |
| Francis Capital Management, LLC | Hedge Fund | 2.4117 | 432432 | -161818 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.8976 | 340238 | -8075 | 2022-12-31 | LOW |
| Shay Capital LLC | Hedge Fund | 1.8962 | 340000 | 0 | 2022-12-31 | HIGH |
| Long Focus Capital Management LLC | Hedge Fund | 1.7469 | 313220 | 5000 | 2022-12-31 | MED |
| Perkins Capital Management, Inc. | Investment Advisor | 1.2164 | 218100 | 0 | 2022-12-31 | LOW |
| LPL Financial LLC | Investment Advisor | 0.8271 | 148300 | 48400 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.7022 | 125910 | -12000 | 2022-12-31 | LOW |
| Raymond James & Associates, Inc. | Research Firm | 0.4978 | 89249 | 71818 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4761 | 85365 | -189 | 2022-12-31 | LOW |
| Fichthorn (John) | Individual Investor | 0.3067 | 55000 | 0 | 2023-03-01 | LOW |
| Citadel Advisors LLC | Hedge Fund | 0.283 | 50746 | 15746 | 2022-12-31 | HIGH |
| Group One Trading, L.P. | Research Firm | 0.2751 | 49322 | 6861 | 2022-12-31 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 0.2186 | 39200 | 500 | 2022-12-31 | HIGH |
| Bencich (John A.) | Individual Investor | 0.2059 | 36920 | 22000 | 2022-11-18 | MED |
| Diametric Capital | Investment Advisor/Hedge Fund | 0.1933 | 34660 | 15153 | 2022-09-30 | HIGH |
| QS Investors, LLC | Investment Advisor/Hedge Fund | 0.1899 | 34050 | 33500 | 2021-06-30 | LOW |
| Millennium Management LLC | Hedge Fund | 0.1697 | 30422 | 30422 | 2022-12-31 | HIGH |
| Clearline Capital LP | Hedge Fund | 0.1515 | 27156 | -92938 | 2022-12-31 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Achieve Life Sciences, Inc. Company profile
Om Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. er en lægemiddelvirksomhed i den kliniske fase. Selskabet beskæftiger sig med udvikling og kommercialisering af cytisiniclin til rygestop og nikotinafhængighed. Selskabets produktkandidat, cytisiniclin, er en naturligt forekommende, plantebaseret alkaloid fra frøene af Laburnum anagyroides-planten. Cytisiniclin ligner strukturelt nikotin og har en virkningsmekanisme, der både er agonistisk og antagonistisk. Det hjælper med rygestop eller nikotinafhængighed ved at interagere med nikotinreceptorer i hjernen ved at reducere sværhedsgraden af nikotinafvænningssymptomer gennem agonistiske virkninger på nikotinreceptorer og ved at reducere den belønning og tilfredsstillelse, der er forbundet med nikotin, gennem antagonistiske egenskaber.
| Industry: | Biotechnology & Medical Research (NEC) |
22722 29Th Dr. Se
Suite 100
SEATTLE
WASHINGTON 98021
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com